Dennis Shelle, MD
Pediatrics · Tecumseh, MINPI 1740244789
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 237 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$697
- Novo Nordisk$635
- AbbVie$476
- Otsuka America Pharmaceutical, Inc.$330
- AstraZeneca$227
- GSK$204
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,153100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 48 | $697 |
| Novo Nordisk | 34 | $635 |
| AbbVie(2 entities) | 28 | $476 |
| Otsuka America Pharmaceutical, Inc. | 18 | $330 |
| AstraZeneca | 11 | $227 |
| GSK | 9 | $204 |
| Lilly USA, LLC | 11 | $199 |
| Dexcom, Inc. | 6 | $178 |
| Ironshore Pharmaceuticals Inc. | 6 | $106 |
| Exact Sciences | 6 | $103 |
| Amgen | 5 | $84 |
| Corium, LLC | 3 | $64 |
| Cranial Technologies, Inc | 4 | $64 |
| Lundbeck LLC | 3 | $62 |
| Grifols USA, LLC | 2 | $54 |
| Mylan Specialty L.p. | 2 | $53 |
| Merck | 3 | $45 |
| Johnson & Johnson | 3 | $43 |
| Boston Scientific | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 3 | $40 |
| Phadia US Inc. | 2 | $38 |
| Novartis | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Corcept Therapeutics | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Shield Therapeutics Inc | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Biocryst US Sales Co., LLC | 2 | $26 |
| Vertical Pharmaceuticals, LLC | 2 | $26 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Bayer | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$4,159 in reported general payments places this provider in the 95th percentile of 1,473 pediatrics providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 128 | $193,088 |
| EliquisApixaban | 147 | $148,136 |
| JardianceEmpagliflozin | 79 | $111,259 |
| RybelsusSemaglutide | 36 | $85,040 |
| XareltoRivaroxaban | 56 | $67,075 |
| JanuviaSitagliptin Phosphate | 39 | $45,701 |
| TrulicityDulaglutide | 29 | $43,875 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $25,606 |
| LinzessLinaclotide | 37 | $24,249 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $24,017 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $17,340 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $15,868 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $14,945 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 511 | $14,549 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 94 | $14,443 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $635 | $278,128164 claims |
| PfizerEliquis, Paxlovid | $697 | $156,115169 claims |
| Johnson & JohnsonXarelto | $43 | $67,07556 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $199 | $55,59343 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $204 | $47,31088 claims |
| MerckJanuvia | $45 | $45,70139 claims |
| AbbVieLinzess | $476 | $24,24937 claims |
| Astellas Pharma US IncMyrbetriq | $15 | $13,41317 claims |
| Sanofi-aventis U.S. LLCLantus | $11 | $4,74620 claims |
| AstraZenecaSymbicort | $227 | $4,62516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,473 pediatrics providers in Michigan.
Other pediatrics in Tecumseh
- Rickey WilsonCaledonia$263K
- Meera ChitlurDetroit$236K
- Randall LejaGrand Rapids$211K
- Madhvi RajpurkarDetroit$162K
- Wanda Whitten-ShurneyDetroit$152K
- Brian LecleirGrand Rapids$145K
- Jeanette CampbellPontiac$94K
- David SvilarAnn Arbor$66K
- Marcus DegrawDetroit$62K
- Allison BannickGrand Rapids$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.